#viralimmunology
His work aims to advance tools for studying antiviral immunity and support the development of Lassa Fever countermeasures.

#ViralImmunology
#LassaFever
#AntibodyResearch
#StructuralBiology
#OxfordScience
July 30, 2025 at 8:55 AM
Last week, our project hosted a seminar with Prof Jörn Walter for a deep dive into the world of epigenomics.
📖 Read more about it in our latest post

www.epivinf.eu/2025/06/25/e...

#Epigenetics #ViralImmunology #EpiAtlas #Genomics
Exploring the Human Epigenome: Insights from Professor Jörn Walter on IHEC and the EpiAtlas – EPIVINF
www.epivinf.eu
June 25, 2025 at 12:33 PM
#NeuroCovid #viralimmunology
Underestimated virus impaired cognition-more evidence and more work to do . Molecular mechanisms associated with viral infection-related #neurodegeneration
www.frontiersin.org/journals/imm...
May 31, 2025 at 4:03 AM
#MedSky🧪#IDSky #publichealth #Virology #viralimmunology The virological characteristics of #SARSCoV2 #XEC
To sum up
🦠 #XEC exhibited more robust #immuneresistance to KP.3.3 BTI sera than KP.3.1.1.
🦠XEC exhibited higher #pseudovirus infectivity and higher #immuneevasion than KP.3 .
October 18, 2024 at 4:38 AM
#MedSky🧪 #IDSky #Publichealth The truth in #LongCovid ,Not all symptoms are the same . #Publichealth #Viralimmunology @HeliyonJournal .The primary outcome is the #postacutesequelae of #COVID19 / #LongCovid in the #digestivesystem .
Symptoms incl
- general tiredness,
- fatigue,
- diarrhea,
September 23, 2024 at 5:55 PM
#MedSky🧪#IDSky #PublicHealth #ImmunoSky #Viralimmunology #Immunity acquired by vaccination following infection, termed #hybridimmunity, has been shown to confer enhanced protection against severe #COVID by enhancing the breadth & potency of #immuneresponses .
August 30, 2024 at 11:46 AM
#MedSky🧪 #IDSky #publichealth #immunoSky #Viralimmunology #Kidney damages associated with #COVID from the acute to the chronic phase. Overview the mechanism in Long-term renal complications of #COVID19 & Kidney function decline #longCovid

www.ncbi.nlm.nih.gov/pmc/articles...
August 12, 2024 at 11:30 AM
#MedSky🧪#IdSky #Publichealth #Viralimmunology @nejm A phase 2–3 double-blind trial to assess the efficacy and safety of #Paxlovix in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact with #COVID19 within 96 hours before randomization.
July 17, 2024 at 10:34 PM
#MedSky🧪 #IDSky #Publichealth #Publichealth #Viralimmunology A recent study analyzed data from more than 200,000 Americans who had #COVID19 twice, revealing that severe #COVID infections tend to predict similarly severe reinfections.
July 12, 2024 at 7:44 PM
#MedSky🧪#IDSky #Viralimmunology #ImmunoSky #Tlymphocytes play a primary role in the #Adaptiveimmunity .Both #lymphocytosis & #lymphopenia were found to be associated with severe #SARSCoV2
July 7, 2024 at 5:25 PM
#MedSky🧪#IDSky #NeuroSky #Neuroinflamation #Neuroimmunology #viralimmunology .This is the 1st #Casereport in 🇧🇬 of a patient with imported malaria in the course of #SARSCoV2 infection .
June 3, 2024 at 12:21 PM
#MedSky🧪 #IDSky #publichealth #Viralimmunology Individuals who completed #Paxlovid treatment for #COVID19 experienced fewer symptoms & lower #ViralLoad but rebound occured more often vs the untreated individuals. Providers should prescribe N/R, when indicated, & communicate rebound risk to patients.
May 30, 2024 at 5:27 PM
#MedSky🧪 #IDSky #NeuroSky #Viralimmunology #Immunology This study highlights the potential toxicity of the #SARSCoV2 Spike protein for mammalian cells & illustrates the central role for #alveolarmacrophage in pathogenic protein uptake.
April 28, 2024 at 12:39 PM
#MedSky🧪 #IDSky #Viralimmunology #Immunology Understanding 🔑 contributor to #COVID19 is #SarsCoV2 ’s utilization of “host shutoff” strategies, optimizing viral replication at the expense of host gene expression and delaying the #Innateimmune response.

www.cell.com/cell-reports...
April 25, 2024 at 4:42 AM
MedSky🧪 #IDSky #Immunosky #NeuroimmunoSky #Viralimmunology This #Clinicalreviews the main #miRNAs studies & their associations with #cognitivedysfunction & physiopathological in molecular processes, other diseases and observations in #COVID19 Patients.
April 17, 2024 at 3:17 PM
MedSky🧪 #IDsky #PublicHealth #Viralimmunology Whether pre-exposure prophylaxis (PrEP) with #tixagevimab/#cilgavimab 150mg/150 mg (T/C) in individuals with #hematologicaldiseases may lead to ⏬️risk of Breakthrough #SARSCoV2 infection/hospitalization or death in #Omicron era remains to be established…
April 12, 2024 at 3:21 PM
MedSky🧪 #IDSky #Viralimmunology #Clinical_ID #Drugsdevelopment perspectives #publichealth @aaas Where do we go wrong ? Pfizer’s antiviral #Paxlovid may not help as many people as hoped. The combo drug was granted emergency use authorization in 2021 in 🇺🇸
April 9, 2024 at 1:21 PM
#Immunology #Viralimmunology #Publchealth Understanding #COVID19 Abzymes . #ACE2-like enzymatic activity is associated with #immunoglobulin in #COVID19 patients

journals.asm.org/doi/10.1128/...
March 29, 2024 at 4:16 PM
MedSky🧪 #IDSky #Viralimmunology #Immunolgy #Evolutionbiology #Microbiology Following the path of #SARSCoV2 infection from the immune response impairment in #PASC / #LongCovid individuals & the potential contribution of different #COVID19pandemic waves & the consequent effects found after infection :
March 25, 2024 at 6:06 PM
MedSky🧪 #IDSky #PublicHealth #Covidheart #Viralimmunology Understanding Pathogenesis of long COVID myocarditis: A comprehensive review
🫀#Myocarditis, a long-term complication of #COVID19 an inflammatory condition involving the myocardium of the heart.
March 22, 2024 at 6:46 PM
MedSky🧪 #IDSky #Cellbiology #Clinical_ID #Viralimmunology This findings provide molecular insights into the mechanisms by which strong viral replication but scarce inflammatory response during the early (ACE2-dependent) infection stage,
March 21, 2024 at 10:46 PM
MedSky🧪 #IDSky #PublicHealth #Viralimmunology Scientists believe they may have found cause of #longCovid.
Two new studies based on an analysis of blood samples of infected people may pave the way for new treatments…

inews.co.uk/news/health/...

@ImperialImmuno 🔗

x.com/imperialimmu...
March 21, 2024 at 6:23 PM